Viking Therapeutics, Inc. (VKTX) Q3 2024 Earnings Call Transcript [Seeking Alpha]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Seeking Alpha
Follow Play Earnings Call Viking Therapeutics, Inc. ( NASDAQ: VKTX ) Q3 2024 Earnings Conference Call October 23, 2024 4:30 PM ET Company Participants Stephanie Diaz – Manager-Investor Relations Brian Lian – President and Chief Executive Officer Greg Zante – Chief Financial Officer Conference Call Participants Joon Lee – Truist Annabel Samimy – Stifel Steve Seedhouse – Raymond James Roger Song – Jefferies Jay Olson – Oppenheimer Justin Zelin – BTIG Thomas Smith – Leerink Partners Yale Jen – Laidlaw & Company Hardik Parikh – JPMorgan Alex Ramsey – William Blair Operator Welcome to the Viking Therapeutics Third Quarter 2024 Financial Results Conference Call. At this time, all parties are in a listen-only mode. Following management's prepared remarks, there will be question-and-answer session. [Operator Instructions] As a reminder, this conference is being recorded today, October 23, 2024. I would now like to turn the conference over to Viking's M
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Viking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek® 2024PR Newswire
- Viking Therapeutics: Q3 Earnings Report Loads A Barrage Of Catalysts [Seeking Alpha]Seeking Alpha
- Why Viking Therapeutics Stock Soared by Nearly 21% on Thursday [Yahoo! Finance]Yahoo! Finance
- VKTX Beats on Q3 Earnings, Stock Up on Obesity Pipeline Advancements [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.MarketBeat
VKTX
Earnings
- 10/23/24 - Beat
VKTX
Sec Filings
- 10/28/24 - Form 4
- 10/28/24 - Form 144
- 10/25/24 - Form 4
- VKTX's page on the SEC website